UK re-investigates Pfizer's eye-popping price gouging on an epilepsy drug
When a drugmaker raises the price of a drug in the US by more than 2,000% overnight, and without any particular reason for that increase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
